The Baldwin Insurance Group, Inc. (BWIN) SEC Filings & Earnings Calls
EquiReason read 14 The Baldwin Insurance Group, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-21 — The Baldwin Insurance Group announced Corbyn Lichon resumed role as Chief Accounting Officer on Sep 21, 2026, and Johnathan Daniel ceased interim CAO role. Routine personnel change.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 4.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
14 Sep 20268-K · 1.01, 7.01Definitive agreement for take-private acquisition by Sequence Holdings and Dell Family Office at $32.50/share, 88% premium, ~$7.7B enterprise value. Baldwin shareholders to receive cash; company to go private.open
Figures in the filing · each found in the filing text
| Enterprise Value · 2026-09-14 | $7.70B | |
| Equity Purchase Price · 2026-09-14 | $4.60B | |
| Net Debt Assumed · 2026-09-14 | $3.10B | |
| Adjusted EBITDA (TTM) · TTM | $396M | |
| Implied EV/EBITDA Multiple · TTM | $20.00 |
Risks flagged
Transaction subject to shareholder and regulatory approvals; risk of non-completion.
“subject to approval by Baldwin shareholders, the receipt of required regulatory approvals, and other customary closing conditions.” · word for word
30 Jul 20268-K · 2.02Total revenue +30%, adjusted EBITDA +37%, adjusted free cash flow +437%; organic growth 2%, normalized organic 8%.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q2-2026 | $493M | +30% y/y |
| Organic revenue growth · Q2-2026 | 2.0% | |
| Net loss · Q2-2026 | $-56M | |
| Diluted loss per share · Q2-2026 | $-0.42 | |
| Adjusted EBITDA · Q2-2026 | $117M | +37% y/y |
| Adjusted EBITDA margin · Q2-2026 | 23.7% | |
| Adjusted net income · Q2-2026 | $69M | |
| Adjusted diluted EPS · Q2-2026 | $0.48 | +14% y/y |
| Net cash provided by operating activities · Q2-2026 | $46M | |
| Adjusted free cash flow · Q2-2026 | $46M | +437% y/y |
Risks flagged
GAAP net loss of $56.0M due to non-cash charges.
“GAAP net loss of $56.0 million” · word for word
Organic growth only 2%, below total growth; reliance on acquisitions.
“Organic revenue growth of 2% year-over-year” · word for word
30 Jul 202610-QBaldwin Insurance Group reported Q2 2026 results with 30% revenue growth but GAAP net loss widened to $(56)M; adjusted EBITDA margin improved to 24%.earningsopen
Figures in the filing · each found in the filing text
| Commissions and fees · Q2-2026 | $489M | +30% y/y |
| Organic revenue growth % · Q2-2026 | 2.0% | |
| Adjusted EBITDA · Q2-2026 | $117M | +37% y/y |
| Adjusted EBITDA margin · Q2-2026 | 24.0% | |
| Adjusted diluted EPS · Q2-2026 | $0.48 | +14% y/y |
| Net income (loss) · Q2-2026 | $-56M | +989% y/y |
| IAS Commissions and fees · Insurance Advisory Solutions · Q2-2026 | $273M | +50% y/y |
| UCTS Commissions and fees · Underwriting, Capacity & Technology Solutions · Q2-2026 | $159M | +9% y/y |
| MIS Commissions and fees · Mainstreet Insurance Solutions · Q2-2026 | $75M | +13% y/y |
| IAS sales velocity · Insurance Advisory Solutions · Q2-2026 | 19.0% |
Risks flagged
Rate softness in commercial property lines
“Organic growth was pressured by a 240 bps headwind in underlying rate and exposure during the current period resulting from continued rate softness, notably in commercial property lines.” · word for word
Medicare Advantage disruption
“The Medicare business has been significantly disrupted by government funding rates associated with Medicare Advantage products, which has caused elevated churn.” · word for word
High leverage and interest expense
“Interest expense, net increased $14.3 million and $23.3 million for the quarter and year-to-date periods ended June 30, 2026 compared to the same periods of 2025, respectively, resulting from higher average borrowings” · word for word
Integration and amortization costs from acquisitions
“Amortization expense increased $30.0 million and $59.2 million for the quarter and year-to-date periods ended June 30, 2026 compared to the same periods of 2025, respectively, driven primarily by the impact of intangible assets recognized in connection with recent partnerships” · word for word
4 Jun 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen
Risks flagged
Temporary leadership gap in accounting function; interim appointment mitigates risk.
“Interim CAO appointed due to maternity leave; no disruption expected.”
4 May 20268-K · 2.02Total revenue $532M (+29% y/y); Organic revenue growth 2; Net loss $-2M; Guidance: Expecting double-digit organic growth run rate by year-end 2026.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q1-2026 | $532M | +29% y/y |
| Organic revenue growth · Q1-2026 | 2.0% | |
| Net loss · Q1-2026 | $-2M | |
| Adjusted EBITDA · Q1-2026 | $137M | +21% y/y |
| Adjusted EBITDA margin · Q1-2026 | 25.8% | |
| Adjusted diluted EPS · Q1-2026 | $0.63 | -3% y/y |
| Adjusted net income · Q1-2026 | $89M | |
| Net cash used in operating activities · Q1-2026 | $-6M | |
| Adjusted free cash flow · Q1-2026 | $-200000.00 | |
| Diluted earnings per share · Q1-2026 | $0.02 |
Guidance
Expecting double-digit organic growth run rate by year-end 2026.
Management raised organic growth outlook, expecting double-digit organic growth run rate by year-end 2026, driven by acquisition synergies and organic execution.
Risks flagged
Margin compression from acquisition integration costs and organic investment.
“Adjusted EBITDA margin declined from 27.5% to 25.8% year-over-year.”
Negative free cash flow in the quarter.
“Adjusted free cash flow of $(0.2) million.”
4 May 202610-QTotal revenues $532M (+29% y/y); Commissions and fees $529M (+29% y/y); Organic revenue growth 2open
Figures in the filing · each found in the filing text
| Total revenues · Q1-2026 | $532M | +29% y/y |
| Commissions and fees · Q1-2026 | $529M | +29% y/y |
| Organic revenue growth · Q1-2026 | 2.0% | |
| Adjusted EBITDA · Q1-2026 | $137M | +21% y/y |
| Adjusted EBITDA margin · Q1-2026 | 26.0% | |
| Net income (loss) · Q1-2026 | $-2M | |
| Adjusted diluted EPS · Q1-2026 | $0.63 | -3% y/y |
| IAS segment revenue · Insurance Advisory Solutions · Q1-2026 | $331M | +45% y/y |
| UCTS segment revenue · Underwriting, Capacity & Technology Solutions · Q1-2026 | $135M | +8% y/y |
| MIS segment revenue · Mainstreet Insurance Solutions · Q1-2026 | $82M | +5% y/y |
Risks flagged
Tax Receivable Agreement Liability
“recorded Tax Receivable Agreement liabilities based on the undiscounted estimated future payments under the Tax Receivable Agreement of $144.6 million.” · word for word
High Leverage and Interest Expense
“Interest expense, net, increased $8.9 million year over year, resulting from higher average borrowings.” · word for word
Organic Growth Deceleration
“Organic revenue growth % (2) 2 % 10 %” · word for word
22 Apr 2026DEF 14ATotal Revenue $1.50B (+8% y/y); Organic Revenue Growth 7; Adjusted EBITDA Margin 22.7open
Figures in the filing · each found in the filing text
| Total Revenue · FY2025 | $1.50B | +8% y/y |
| Organic Revenue Growth · FY2025 | 7.0% | |
| Adjusted EBITDA Margin · FY2025 | 22.7% | |
| Adjusted Net Income · FY2025 | $199M | +12% y/y |
| Adjusted Diluted EPS · FY2025 | $1.67 | +11% y/y |
| GAAP Net Loss · FY2025 | $-54M | |
| Pro Forma Adjusted EBITDA · FY2025 | $353M | +13% y/y |
Risks flagged
GAAP Net Loss and Negative GAAP EPS
“reported a 32% increase in GAAP net loss to $54.2 million and a net loss margin of 4%, and our GAAP diluted loss per share increased 28% to $0.50.” · word for word
Concentrated Voting Control
“Lowry Baldwin beneficially owns 19,779,371 shares of Class B common stock, representing 43.7% of that class and 14.1% combined voting power.”
Tax Receivable Agreement Obligation
“recorded Tax Receivable Agreement liabilities based on the undiscounted estimated future payments under the Tax Receivable Agreement of $144.6 million.”
26 Feb 202610-KCash and cash equivalents $124M; Available borrowing capacity $477M; Total consolidated debt outstanding $1.70Bopen
Figures in the filing · each found in the filing text
| Cash and cash equivalents · FY2025 | $124M | |
| Available borrowing capacity · FY2025 | $477M | |
| Total consolidated debt outstanding · FY2025 | $1.70B | |
| Debt servicing costs · FY2025 | $279M | |
| Goodwill · FY2025 | $1.50B | |
| Contingent earnout liabilities · FY2025 | $23M |
Risks flagged
High leverage and debt service burden
“As of December 31, 2025, we had total consolidated debt outstanding of approximately $1.7 billion... During the year ended December 31, 2025, we had debt servicing costs of $279.1 million” · word for word
Goodwill impairment risk
“As of December 31, 2025, we had $1.5 billion of goodwill recorded on our balance sheet, which represented 39% of our total assets.” · word for word
Contingent earnout cash flow risk
“In connection with our partnership with CAC Group... we are required to pay a deferred cash consideration payment of $70.0 million in 2030 and a contingent earnout of up to $250.0 million.” · word for word
Insurance market cyclicality
“Downward fluctuations in the year-over-year insurance premiums charged by our insurance company partners to protect against the same risk, referred to in the industry as softening of the insurance market, could adversely affect our business” · word for word
26 Feb 20268-K · 2.02Total Revenue $1.50B (+8% y/y); Organic Revenue Growth 7; Adjusted EBITDA $342M (+9% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · FY2025 | $1.50B | +8% y/y |
| Organic Revenue Growth · FY2025 | 7.0% | |
| Adjusted EBITDA · FY2025 | $342M | +9% y/y |
| Adjusted EBITDA Margin · FY2025 | 22.7% | |
| Adjusted Diluted EPS · FY2025 | $1.67 | +11% y/y |
| GAAP Net Loss · FY2025 | $54M | |
| Adjusted Free Cash Flow · FY2025 | $87M | |
| Cash and Cash Equivalents · Q4-2025 | $124M | |
| Revolving Credit Facility Capacity · Q4-2025 | $477M |
Risks flagged
GAAP net loss persists despite adjusted profitability, indicating significant non-cash charges or acquisition-related costs
“GAAP net loss of $54.2 million for FY2025 and $43.7 million for Q4 2025” · word for word
2 Jan 20268-K · 1.01, 2.01, 2.03, 3.02, 5.02Entered a material definitive agreement (acquisition, partnership, or major contract); completed an acquisition or disposition of significant assetsopen
Risks flagged
Increased leverage from $600M incremental debt; integration risk from Cobbs Allen acquisition.
“incremental term B loans...increasing aggregate principal to approximately $1,601 million”
2 Dec 20258-K · 1.01, 3.02, 7.01Total upfront consideration $1.03B; Cash consideration $438M; Stock consideration (shares) 23,200,000open
Figures in the filing · each found in the filing text
| Total upfront consideration · 2025-12-02 | $1.03B | |
| Cash consideration · 2025-12-02 | $438M | |
| Stock consideration (shares) · 2025-12-02 | 23,200,000 | |
| Implied multiple of 2025E Pro Forma Adjusted EBITDA · 2025E | $7.90 | |
| Performance-based earnout · 2025-12-02 | $250M | |
| Deferred payment · 2025-12-02 | $70M | |
| 2026E Gross Revenue · FY2026 | $2.00B | |
| 2026E Adjusted EBITDA · FY2026 | $470M |
Risks flagged
Integration risk; transaction expected to close in Q1 2026 subject to regulatory approvals; leverage neutral at close.
“The transaction is expected to close in the first quarter of 2026, subject to customary closing conditions and regulatory approvals.” · word for word
4 Nov 20258-K · 2.02Total revenue $365M (+8% y/y); Organic revenue growth 5; GAAP net loss $-30Mearningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q3-2025 | $365M | +8% y/y |
| Organic revenue growth · Q3-2025 | 5.0% | |
| GAAP net loss · Q3-2025 | $-30M | |
| Adjusted diluted EPS · Q3-2025 | $0.31 | -6% y/y |
| Adjusted EBITDA · Q3-2025 | $73M | 0% y/y |
| Adjusted EBITDA margin · Q3-2025 | 19.8% | |
| Net cash provided by operating activities · Q3-2025 | $41M | |
| Adjusted free cash flow · Q3-2025 | $42M | +26% y/y |
| Cash and cash equivalents · Q3-2025 | $90M |
Risks flagged
Margin compression from investments and operating leverage
“Adjusted EBITDA margin declined from 21.5% to 19.8% YoY”
4 Nov 202510-QBaldwin Insurance reported Q3 2025 results with total revenue +8% YoY but net loss widened to $30.2M; adjusted EBITDA margin contracted 100 bps.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $365M | +8% y/y |
| Adjusted EBITDA · Q3-2025 | $73M | 0% y/y |
| Adjusted EBITDA margin · Q3-2025 | 20.0% | |
| Organic revenue growth · Q3-2025 | 5.0% | |
| Adjusted diluted EPS · Q3-2025 | $0.31 | -6% y/y |
| Net loss · Q3-2025 | $-30M | +109% y/y |
Risks flagged
Insurance rate softening
“Organic growth was pressured by 570 bps of headwind in underlying rate and exposure during the quarter, attributable to softening insurance rates.” · word for word
Captive business losses
“Other operating expenses increased $7.2 million for the quarter... driven by higher incurred losses and LAE of $5.1 million related to our newly-established Captive business.” · word for word
Debt refinancing costs
“Loss on extinguishment and modification of debt of $3.3 million for the quarter ended September 30, 2025 relates to the September 2025 Refinancing.” · word for word
The Baldwin Insurance Group, Inc. — questions
- What did The Baldwin Insurance Group, Inc. file recently?
- 14 SEC filings in the last 12 months. Latest: 8-K on 2026-09-21 — The Baldwin Insurance Group announced Corbyn Lichon resumed role as Chief Accounting Officer on Sep 21, 2026, and Johnathan Daniel ceased interim CAO role. Routine personnel change.
Every figure on this page comes from The Baldwin Insurance Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.